Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age

This publication has 14 references indexed in Scilit:

• Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
  Journal of Clinical Oncology, 2006
• Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
  The Lancet Oncology, 2005
• High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG‐1) by the European Neuroblastoma Study Group
  Pediatric Blood & Cancer, 2004
• Disseminated Neuroblastoma in Children Older Than One Year at Diagnosis: Comparable Results With Three Consecutive High-Dose Protocols Adopted by the Italian Co-Operative Group for Neuroblastoma
  Journal of Clinical Oncology, 2003
• Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma
  Journal of Clinical Oncology, 2002
• High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during ¹³¹I‐meta‐iodobenzylguanidine treatment in children with neuroblastoma
  Cancer, 2002
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
  New England Journal of Medicine, 1999
• Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study
  European Journal Of Cancer, 1998
• Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma
  European Journal Of Cancer, 1995
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
  Journal of Clinical Oncology, 1993